(Q33619234)

28 July 2017

Clinical pharmacology of pyridostigmine and neostigmine in patients with myasthenia gravis (English)

1 reference

28 July 2017

0 references

1 reference

1 reference

Aquilonius SM

1

1 reference

28 July 2017

Eckernäs SA

2

1 reference

28 July 2017

Hartvig P

3

1 reference

28 July 2017

Lindström B

4

1 reference

28 July 2017

Osterman PO

5

1 reference

28 July 2017

Stålberg E

6

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 October 1983

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

28 July 2017

1 reference

28 July 2017

46

1 reference

28 July 2017

10

1 reference

28 July 2017

929-935

1 reference

The relationship of plasma levels of pyridostigmine to clinical effect in patients with myasthenia gravis

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027607

Single-muscle-fiber recording of the jitter phenomenon in patients with myasthenia gravis and in members of their families

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027607

ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027607

A pharmacokinetic study of neostigmine in man using gas chromatography-mass spectrometry

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027607

Plasma concentration of pyridostigmine and effects in myasthenia gravis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1027607

Metabolism of 14C-labeled pyridostigmine in myasthenia gravis: Evidence for multiple metabolites

21 June 2018

1 reference

12 December 2020

STUDIES IN MYASTHENIA GRAVIS. 1. A CLINICAL STUDY OF 180 PATIENTS

1 reference

12 December 2020

The pharmacokinetics of pyridostigmine

1 reference

12 December 2020

Plasma pyridostigmine levels in patients with myasthenia gravis

1 reference

12 December 2020

Renal Clearance of Pyridostigmine in Patients with Myasthenia gravis

1 reference

12 December 2020

Clearance of neostigmine from the circulation during the antagonism of neuromuscular block

1 reference

12 December 2020

Pyridostigmine kinetics with and without renal function

1 reference

12 December 2020

Pharmacokinetics and oral bioavailability of pyridostigmine in man

1 reference

12 December 2020

Plasma pyridostigmine levels in myasthenia gravis

1 reference

12 December 2020

The effect of neostigmine on pyridostigmine bioavailability in myasthenic patients after oral administration

1 reference

12 December 2020

A quantitative gas-liquid chromatographic method for the determination of neostigmine and pyridostigmine in human plasma

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.46.10.929

1 reference

28 July 2017

1 reference

28 July 2017

1 reference